Leila A. Mashouf

615 total citations
10 papers, 239 citations indexed

About

Leila A. Mashouf is a scholar working on Genetics, Oncology and Neurology. According to data from OpenAlex, Leila A. Mashouf has authored 10 papers receiving a total of 239 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Genetics, 4 papers in Oncology and 3 papers in Neurology. Recurrent topics in Leila A. Mashouf's work include Glioma Diagnosis and Treatment (4 papers), Nanoparticle-Based Drug Delivery (2 papers) and Brain Metastases and Treatment (2 papers). Leila A. Mashouf is often cited by papers focused on Glioma Diagnosis and Treatment (4 papers), Nanoparticle-Based Drug Delivery (2 papers) and Brain Metastases and Treatment (2 papers). Leila A. Mashouf collaborates with scholars based in United States, Taiwan and Germany. Leila A. Mashouf's co-authors include Michael Lim, Ya-Jui Lin, Vladimir A. Ljubimov, Julia Y. Ljubimova, Eggehard Holler, Alexander V. Ljubimov, Liron L. Israel, Tao Sun, Yuanxuan Xia and Chetan Bettegowda and has published in prestigious journals such as Advanced Drug Delivery Reviews, Scientific Reports and Journal of Controlled Release.

In The Last Decade

Leila A. Mashouf

10 papers receiving 238 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Leila A. Mashouf United States 7 72 70 69 63 45 10 239
Milena Guidi Italy 7 104 1.4× 59 0.8× 98 1.4× 70 1.1× 34 0.8× 23 280
Gabriella Baio Italy 9 132 1.8× 58 0.8× 47 0.7× 62 1.0× 61 1.4× 18 361
Simon Khagi United States 9 101 1.4× 72 1.0× 110 1.6× 113 1.8× 28 0.6× 28 325
Clemens Reinshagen United States 11 108 1.5× 53 0.8× 75 1.1× 80 1.3× 16 0.4× 20 343
Riccardo Serra United States 10 114 1.6× 116 1.7× 102 1.5× 43 0.7× 137 3.0× 25 369
Yong Xiao China 12 168 2.3× 89 1.3× 50 0.7× 75 1.2× 45 1.0× 41 392
Daniele Boso Italy 11 165 2.3× 72 1.0× 45 0.7× 41 0.7× 69 1.5× 13 316
Yuriy Zozulya Ukraine 9 169 2.3× 42 0.6× 30 0.4× 47 0.7× 46 1.0× 32 317
Anton Wohl Israel 8 145 2.0× 55 0.8× 62 0.9× 24 0.4× 62 1.4× 14 304
Mònica Vilà-Ubach Spain 10 142 2.0× 61 0.9× 19 0.3× 105 1.7× 61 1.4× 15 345

Countries citing papers authored by Leila A. Mashouf

Since Specialization
Citations

This map shows the geographic impact of Leila A. Mashouf's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leila A. Mashouf with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leila A. Mashouf more than expected).

Fields of papers citing papers by Leila A. Mashouf

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Leila A. Mashouf. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leila A. Mashouf. The network helps show where Leila A. Mashouf may publish in the future.

Co-authorship network of co-authors of Leila A. Mashouf

This figure shows the co-authorship network connecting the top 25 collaborators of Leila A. Mashouf. A scholar is included among the top collaborators of Leila A. Mashouf based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Leila A. Mashouf. Leila A. Mashouf is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Blitz, Sarah E., Leila A. Mashouf, Jason Matos, et al.. (2023). Prevalence and Predictors of Inappropriate Antithrombotic Prescription in Patients Presenting With Traumatic Brain Injury. Neurosurgery. 93(5). 1019–1025. 1 indexed citations
2.
Lin, Ya-Jui, Leila A. Mashouf, & Michael Lim. (2022). CAR T Cell Therapy in Primary Brain Tumors: Current Investigations and the Future. Frontiers in Immunology. 13. 817296–817296. 74 indexed citations
3.
Zaki, Mark M., Leila A. Mashouf, E. L. Woodward, et al.. (2021). Genomic landscape of gliosarcoma: distinguishing features and targetable alterations. Scientific Reports. 11(1). 18009–18009. 15 indexed citations
4.
Jackson, Christopher M., Yuanxuan Xia, Leila A. Mashouf, et al.. (2019). Retrosigmoid approach for glycerin rhizotomy in the treatment of trigeminal neuralgia without overt arterial compression: updated case series. Journal of neurosurgery. 132(4). 1227–1233. 5 indexed citations
5.
Xia, Yuanxuan, Leila A. Mashouf, Risheng Xu, et al.. (2019). Absence of Ischemic Injury after Sacrificing the Superior Petrosal Vein during Microvascular Decompression. Operative Neurosurgery. 18(3). 316–320. 12 indexed citations
6.
Liew, Jason, Wuyang Yang, Leila A. Mashouf, et al.. (2019). Incidence of Spontaneous Obliteration in Untreated Brain Arteriovenous Malformations. Neurosurgery. 86(1). 139–149. 13 indexed citations
7.
Lim, Michael, et al.. (2018). Adjuvant radiotherapy and outcomes of presumed hemorrhagic melanoma brain metastases without malignant cells. Surgical Neurology International. 9(1). 146–146. 6 indexed citations
8.
Xia, Yuanxuan, Leila A. Mashouf, Brock R. Baker, et al.. (2018). Outcomes of Metastatic Brain Lesions Treated with Radioactive Cs-131 Seeds after Surgery: Experience from One Institution. Cureus. 10(7). e3075–e3075. 6 indexed citations
9.
Ljubimova, Julia Y., Tao Sun, Leila A. Mashouf, et al.. (2017). Covalent nano delivery systems for selective imaging and treatment of brain tumors. Advanced Drug Delivery Reviews. 113. 177–200. 65 indexed citations
10.
Chou, Szu‐Ting, Rameshwar Patil, Anna Galstyan, et al.. (2016). Simultaneous blockade of interacting CK2 and EGFR pathways by tumor-targeting nanobioconjugates increases therapeutic efficacy against glioblastoma multiforme. Journal of Controlled Release. 244(Pt A). 14–23. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026